sk&f 106760 has been researched along with fibrin in 1 studies
Studies (sk&f 106760) | Trials (sk&f 106760) | Recent Studies (post-2010) (sk&f 106760) | Studies (fibrin) | Trials (fibrin) | Recent Studies (post-2010) (fibrin) |
---|---|---|---|---|---|
9 | 0 | 0 | 15,994 | 328 | 3,808 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boppana, V; Koster, PF; Miller-Stein, C; Nichols, AJ; Rhodes, GR; Samanen, JM; Valocik, RE; Vasko, JA | 1 |
1 other study(ies) available for sk&f 106760 and fibrin
Article | Year |
---|---|
The in vivo pharmacological profile of the novel glycoprotein IIb/IIIa antagonist, SK&F 106760.
Topics: Animals; Blood Platelets; Coronary Thrombosis; Dogs; Fibrin; Male; Peptides, Cyclic; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Streptokinase | 1994 |